SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000875320-14-000019
Filing Date
2014-03-28
Accepted
2014-03-28 16:05:57
Documents
10
Period of Report
2014-05-07
Effectiveness Date
2014-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2014proxy.htm DEF 14A 1681478
3 a2014chart1.jpg GRAPHIC 11330
4 a2014chart2.jpg GRAPHIC 19363
5 a2014proxycard1.jpg GRAPHIC 407782
6 a2014proxycard2.jpg GRAPHIC 351887
7 jmlsig.gif GRAPHIC 2203
8 klhsig.jpg GRAPHIC 39795
9 proxycover2014_b.jpg GRAPHIC 767550
10 vertexlogo01.jpg GRAPHIC 28782
11 vertexlogo02.jpg GRAPHIC 28782
  Complete submission text file 0000875320-14-000019.txt   3967245
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19319 | Film No.: 14725764
SIC: 2834 Pharmaceutical Preparations